Clinical Trial Update: Combination Therapy in Cancers With Mutations in DNA Repair Genes [Phase 1]

View source ↗

Summary

Phase 1 study of a combination therapy for metastatic solid tumors with DNA repair gene mutations (BRCA1/BRCA2/ATM/PALB2) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Snippet

Sponsor: University of California, San Francisco | Conditions: Metastatic Solid Tumor, BRCA1 Mutation | Phase 1 | Status: RECRUITING